Related Experiment Video
Updated: Jan 22, 2026

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
Published on: December 14, 2014
Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study
Florencia Carbone1, Karen Van den Houte1, Egbert Clevers1
1Translational Research Center for Gastrointestinal Disorders (TARGID), University of Leuven, Leuven, Belgium.
Prucalopride significantly improved gastroparesis symptoms and quality of life in a clinical trial. This selective 5-hydroxytryptamine 4 receptor agonist also enhanced gastric emptying, offering a promising treatment for gastroparesis.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Prokinetics are the preferred treatment for gastroparesis, but evidence for their efficacy is limited.
- Prucalopride, a selective 5-hydroxytryptamine 4 receptor agonist, enhances gastric emptying and is used for constipation.
Purpose of the Study:
- To evaluate the efficacy of prucalopride in improving gastric emptying rate and symptoms in patients with gastroparesis.
Main Methods:
- A double-blind, randomized, placebo-controlled crossover study involving 34 patients with gastroparesis.
- Patients received 4-week treatment periods of placebo or prucalopride (2 mg q.d.), separated by a 2-week washout.
- Outcomes included the Gastroparesis Cardinal Symptom Index, quality of life assessments, and gastric emptying rate via C-octanoic acid breath test.
Main Results:
- Prucalopride significantly improved total Gastroparesis Cardinal Symptom Index scores compared to placebo (P < 0.0001).
- Improvements were observed in fullness, nausea, vomiting, bloating, and quality of life domains.
- Gastric half emptying time was significantly enhanced by prucalopride (P = 0.005).
Conclusions:
- Four weeks of prucalopride treatment significantly improved symptoms and quality of life in patients with gastroparesis.
- Prucalopride demonstrated efficacy in enhancing gastric emptying in this patient cohort.
Related Concept Videos
The Placebo Effect
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Random Error
Random Variables
Uppercase letters such as X or Y denote a random variable. Lowercase letters like x or y denote the value of a random variable. If X is a random variable, then X is written in words, and x is given as a number.
For example, let X = the...

